Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00203372 | Neoadjuvant TAC Plus or Minus Bevacizumab(AVF3299) | completed | Phase 2 | 6 | Translational Oncology Research InternationalOTHER | 3 | Oct 12, 2015 | clinicaltrials |
| NCT01068704 | Efficacy and Safety of BMS-690514 in Combination With Letrozole to Treat Metastatic Breast Cancer | completed | Phase 2 | 4 | Bristol-Myers SquibbINDUSTRY | 4 | Oct 12, 2015 | clinicaltrials |
| NCT00377559 |
| Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast Cancer(MYOTAX) |
| completed |
| Phase 2 |
| 70 |
| Catharina Ziekenhuis EindhovenOTHER |
| 1 |
| Oct 6, 2015 |
| clinicaltrials |
| NCT01004081 | Hormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule Finding | completed | Phase 2 | 54 | BiogenINDUSTRY | 4 | Oct 2, 2015 | clinicaltrials |
| NCT00694252 | Lapatinib and Circulating Tumor Cells in Breast Cancer | completed | Phase 2 | 20 | University Hospital of CreteOTHER | 1 | Sep 28, 2015 | clinicaltrials |
| NCT00095706 | Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF) | completed | Phase 1 / Phase 2 | 50 | Translational Oncology Research InternationalOTHER | 1 | Sep 25, 2015 | clinicaltrials |
| NCT01176669 | Study of Apatinib in Metastatic Triple-Negative Breast Cancer Patients | completed | Phase 2 | 60 | Fudan UniversityOTHER | 1 | Sep 9, 2015 | clinicaltrials |
| NCT01550848 | A Phase II Study of Abraxane Gemcitabine Combination in Patients With Metastatic Breast Cancer | completed | Phase 2 | 84 | Fudan UniversityOTHER | 1 | Sep 9, 2015 | clinicaltrials |
| NCT01658033 | Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) Patients | completed | Phase 2 | 72 | Fudan UniversityOTHER | 1 | Sep 9, 2015 | clinicaltrials |
| NCT01797354 | Impact of a Group Intervention on Breast Cancer Patient's Adjustment and Emotion Regulation at the End of Treatment | completed | Phase 2 | 260 | Université Libre de BruxellesOTHER | 1 | Sep 4, 2015 | clinicaltrials |
| NCT01606072 | Perioperative Use of Desmopressin (DDAVP) in Breast Cancer | completed | Phase 2 | 21 | Laboratorio Elea Phoenix S.A.INDUSTRY | 1 | Aug 28, 2015 | clinicaltrials |
| NCT00736970 | Oral Deforolimus With Trastuzumab for Patients With HER2-positive Trastuzumab-Refractory Metastatic Breast Cancer (8669-009) | completed | Phase 2 | 34 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 27, 2015 | clinicaltrials |
| NCT02491892 | A Study of Pertuzumab in Participants With Metastatic Breast Cancer | completed | Phase 2 | 79 | Hoffmann-La RocheINDUSTRY | 8 | Aug 25, 2015 | clinicaltrials |
| NCT00166543 | Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer | completed | Phase 2 | 146 | SRI InternationalINDUSTRY | 1 | Aug 18, 2015 | clinicaltrials |
| NCT01281904 | Acupressure for Persistent Cancer Related Fatigue(AcuCrft) | completed | Phase 2 / Phase 3 | 288 | University of MichiganOTHER | 1 | Aug 6, 2015 | clinicaltrials |
| NCT00004092 | Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer | completed | Phase 2 | 72 | City of Hope Medical CenterOTHER | 1 | Aug 4, 2015 | clinicaltrials |
| NCT00909506 | Efficacy and Safety of Adjuvant Metformin for Operable Breast Cancer Patients | completed | Phase 2 | 105 | Seoul National University HospitalOTHER | 1 | Jul 29, 2015 | clinicaltrials |
| NCT00054145 | Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer | completed | Phase 2 | — | University Health Network, TorontoOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT00952731 | 4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ | completed | Phase 2 | 27 | Northwestern UniversityOTHER | 1 | Jul 21, 2015 | clinicaltrials |
| NCT00109265 | A Study to Evaluate Erlotinib in Patients With Advanced or Metastatic Breast Cancer During or Following Chemotherapy | completed | Phase 2 | — | Genentech, Inc.INDUSTRY | 0 | Jul 2, 2015 | clinicaltrials |
| NCT00201773 | Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer | completed | Phase 2 | 22 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jun 30, 2015 | clinicaltrials |
| NCT00990977 | Mindfulness and Cancer Mamma - Clinical Trial MBSR Among Women Operated for Breast Cancer(MICA) | completed | Phase 2 / Phase 3 | 336 | Danish Cancer SocietyOTHER | 1 | Jun 30, 2015 | clinicaltrials |
| NCT01487954 | Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy | completed | Phase 2 | 45 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 18, 2015 | clinicaltrials |
| NCT00855452 | Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors(rIL-2(LAK)) | completed | Phase 2 | 20 | Hadassah Medical OrganizationOTHER | 1 | Jun 11, 2015 | clinicaltrials |
| NCT02468050 | Study of Exercise to Manage Distress During Breast Screening | completed | Phase 2 | 7 | University of Western Ontario, CanadaOTHER | 1 | Jun 10, 2015 | clinicaltrials |
| NCT02460744 | 2-weeks of Adjuvant Radiotherapy in Patients With Breast Cancer | completed | Phase 2 | 50 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Jun 2, 2015 | clinicaltrials |
| NCT00392184 | Partial Breast Irradiation With Multi-Catheter Brachytherapy for pT1-2pN0 Breast Cancer After Breast Conserving Surgery | completed | Phase 2 | 274 | University of Erlangen-Nürnberg Medical SchoolOTHER | 2 | Jun 1, 2015 | clinicaltrials |
| NCT00584766 | Intensive Combo Chemo With Autologous BM Rescue for Metastatic Breast Cancer | completed | Phase 2 | 21 | University of OklahomaOTHER | 1 | May 29, 2015 | clinicaltrials |
| NCT01242449 | Oral Vinorelbine in Combination With Trastuzumab for Metastatic Breast Cancer(OVINTRA) | completed | Phase 2 | 10 | Vejle HospitalOTHER | 1 | May 21, 2015 | clinicaltrials |
| NCT00894504 | Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer | completed | Phase 2 | 71 | SCRI Development Innovations, LLCOTHER | 1 | May 15, 2015 | clinicaltrials |
| NCT00930930 | Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer | completed | Phase 2 | 145 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | May 7, 2015 | clinicaltrials |
| NCT00070252 | Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer | completed | Phase 1 / Phase 2 | 53 | National Cancer Institute (NCI)NIH | 1 | May 4, 2015 | clinicaltrials |
| NCT01432223 | Primary Chemotherapy With Anthracycline Followed by Nab-paclitaxel and Trastuzumab | completed | Phase 2 | 46 | Osaka Medical CollegeOTHER | 1 | Apr 22, 2015 | clinicaltrials |
| NCT00051103 | Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin. | completed | Phase 2 | — | GlaxoSmithKlineINDUSTRY | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00081510 | Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480) | completed | Phase 2 | 110 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Apr 15, 2015 | clinicaltrials |
| NCT01540955 | Cognitive Rehabilitation Group Intervention for Breast Cancer Survivors | completed | Phase 2 | 48 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Apr 10, 2015 | clinicaltrials |
| NCT01204957 | Brown Seaweed as a Breast Cancer Preventive | completed | Phase 1 / Phase 2 | 33 | University of South CarolinaOTHER | 1 | Apr 6, 2015 | clinicaltrials |
| NCT00209092 | Randomized Phase II Trial Induction Therapy for Early Stage Breast Cancer | completed | Phase 2 | 51 | Emory UniversityOTHER | 1 | Mar 27, 2015 | clinicaltrials |
| NCT01785992 | A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer.(IRIS) | completed | Phase 2 | 27 | Imperial College LondonOTHER | 1 | Mar 24, 2015 | clinicaltrials |
| NCT00054028 | Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer | completed | Phase 1 / Phase 2 | 31 | National Cancer Institute (NCI)NIH | 1 | Mar 17, 2015 | clinicaltrials |
| NCT02015676 | A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Metastatic or Locally Advanced Breast Cancer | completed | Phase 1 / Phase 2 | 69 | Hoffmann-La RocheINDUSTRY | 1 | Mar 12, 2015 | clinicaltrials |
| NCT00548899 | Neoadjuvant Chemotherapy Including Sorafenib in Women With Previously Untreated Primary Breast Cancer(SOFIA) | completed | Phase 2 | 36 | GBG Forschungs GmbHOTHER | 1 | Mar 9, 2015 | clinicaltrials |
| NCT01069081 | Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer | completed | Phase 2 | 94 | Fudan UniversityOTHER | 1 | Mar 6, 2015 | clinicaltrials |
| NCT00704158 | Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 42 | CuraGen CorporationINDUSTRY | 1 | Feb 19, 2015 | clinicaltrials |
| NCT00479674 | Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer(ABC) | completed | Phase 2 | 41 | Duke UniversityOTHER | 1 | Feb 18, 2015 | clinicaltrials |
| NCT00951054 | A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer | completed | Phase 2 | 61 | Nippon Kayaku Co., Ltd.INDUSTRY | 1 | Feb 16, 2015 | clinicaltrials |
| NCT01368107 | Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients | completed | Phase 2 | 24 | Centre Leon BerardOTHER | 1 | Feb 9, 2015 | clinicaltrials |
| NCT02190227 | RNA Disruption Assay (RDA) Response Prediction in Neoadjuvant Chemotherapy Breast Cancer Treatment | completed | Phase 2 | 30 | Jewish General HospitalOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT01386580 | An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma. | completed | Phase 1 / Phase 2 | 84 | BBB-Therapeutics B.V.INDUSTRY | 4 | Jan 22, 2015 | clinicaltrials |
| NCT01483001 | Feasibility Study on Stem Cells Sensitivity Assay(STELLA) | completed | Phase 2 | 23 | Associazione Oncologia TraslazionaleOTHER | 1 | Jan 14, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Oct 12, 2015source: clinicaltrials